← Open Payments lookup

KATRINA BLACKARD: Open Payments

NPI 1467051029 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,476 in 162 payments from 24 companies in 2025. Trend: 2023 $3,208 · 2024 $3,141 · 2025 $3,476

Food & beverage: $3,459Education: $17
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$630
GlaxoSmithKline, LLC.27$389
HARMONY BIOSCIENCES LLC10$313
Regeneron Healthcare Solutions, Inc.10$291
Insmed, Inc.13$191
Boehringer Ingelheim Pharmaceuticals, Inc.10$190
GENZYME CORPORATION8$190
Actelion Pharmaceuticals US, Inc.12$186
Viatris Specialty LLC7$176
Pulmonx Corporation1$150

Products named: DUPIXENT, FASENRA, WAKIX, NUCALA, TEZSPIRE, YUPELRI, Arikayce, CHARTIS CATHETER.

Industry payments across MS — which companies pay providers there.